The Small Animal Imaging (In Vivo) Market is estimated to be valued at USD 1.3 billion in 2025 and is projected to reach USD 2.7 billion by 2035, registering a compound annual growth rate (CAGR) of 7.7% over the forecast period.
-market-market-value-analysis.webp "Small Animal Imaging (in Vivo) Market Market Value Analysis")
| Metric | Value |
|---|---|
| Small Animal Imaging (In Vivo) Market Estimated Value in (2025 E) | USD 1.3 billion |
| Small Animal Imaging (In Vivo) Market Forecast Value in (2035 F) | USD 2.7 billion |
| Forecast CAGR (2025 to 2035) | 7.7% |
The small animal imaging (in vivo) market is experiencing strong expansion, supported by its critical role in preclinical research, drug development, and molecular biology studies. Increasing demand for precise imaging modalities to evaluate disease progression, treatment responses, and biological mechanisms in living organisms is driving adoption. Rising investments from pharmaceutical companies and academic research institutions are enhancing the use of in vivo imaging systems to accelerate translational research and reduce failure rates in later-stage clinical trials.
Continuous advancements in imaging technologies, including improvements in resolution, sensitivity, and multi-modal integration, are broadening the scope of applications. Ethical and regulatory frameworks that encourage non-invasive imaging methods are also promoting growth, as they allow for longitudinal studies while minimizing animal usage.
As personalized medicine, oncology research, and molecular diagnostics continue to advance, the role of small animal imaging technologies is expected to expand further The market outlook remains positive as increasing collaborations between academia and industry drive innovation and ensure continued adoption of advanced in vivo imaging systems worldwide.
The small animal imaging (in vivo) market is segmented by application, technology, and geographic regions. By application, small animal imaging (in vivo) market is divided into Cancer Cell Detection, Monitoring Drug Treatment Response, Bio Distribution Studies, Biomarkers, Longitudinal Studies, and Epigenetics. In terms of technology, small animal imaging (in vivo) market is classified into Micro-Magnetic Resonance Imaging (Micro-MRI), Digital Angiography, Ultrasound, Nuclear Imaging, Micro-Positron Emission Tomography (Micro-PET), Micro-Single Photon Emission CT (Micro-SPECT), Optical Imaging (OI), Bioluminescence Imaging, Cerenkov Luminescence Imaging, Others, Micro-Ultrasound Imaging, and Micro-Computerized Tomography (Micro-CT). Regionally, the small animal imaging (in vivo) industry is classified into North America, Latin America, Western Europe, Eastern Europe, Balkan & Baltic Countries, Russia & Belarus, Central Asia, East Asia, South Asia & Pacific, and the Middle East & Africa.
-market-analysis-by-application.webp "Small Animal Imaging (in Vivo) Market Analysis By Application")
The cancer cell detection segment is projected to hold 28.9% of the small animal imaging (in vivo) market revenue share in 2025, making it the leading application area. Its dominance is being reinforced by the rising global focus on oncology research and the increasing need for precise, real-time imaging techniques to study tumor development and evaluate therapeutic interventions. The segment is benefitting from growing research funding and collaborative initiatives aimed at developing innovative cancer treatments.
Small animal imaging technologies are enabling researchers to track cancer progression, metastasis, and treatment response in vivo, significantly improving the predictive accuracy of preclinical studies. Non-invasive imaging allows repeated measurements within the same animal, enhancing data consistency and reducing variability across studies.
The ability to visualize cancer cell behavior at cellular and molecular levels has positioned this application as a cornerstone of translational research As cancer incidence continues to rise globally and demand for advanced therapies increases, cancer cell detection in preclinical models is expected to remain a dominant application within the small animal imaging market.
-market-analysis-by-technology.webp "Small Animal Imaging (in Vivo) Market Analysis By Technology")
The micro-magnetic resonance imaging (micro-MRI) segment is anticipated to represent 22.9% of the small animal imaging (in vivo) market revenue share in 2025, positioning it as the leading technology segment. Its growth is being supported by the ability to provide high-resolution, three-dimensional anatomical images without exposing animals to ionizing radiation. Micro-MRI technology is widely recognized for its superior soft tissue contrast and capacity to evaluate structural and functional changes in vivo, making it particularly valuable for studies in oncology, neurology, and cardiovascular research.
The segment is gaining momentum from its role in longitudinal studies, as it enables repeated imaging of the same subject to assess disease progression or therapeutic impact over time. Advances in imaging protocols and magnet design are improving resolution and scan efficiency, making the technology more accessible to research institutions.
With growing emphasis on reducing animal usage while obtaining comprehensive datasets, micro-MRI has become a preferred modality As research intensity increases in both academic and pharmaceutical sectors, the technology is expected to sustain its leadership position within the market.
Small animal imaging (In vivo) is a technique used for imaging biological processes in living animals which shows the changes in cellular activity to study the effect of drugs and disease progression. Small animal imaging is used in clinical research for drug development. Small animal imaging helps to study the drug assessment on various diseases.
The small animal imaging includes whole body scan of small animals which is a cost effective method for regular validation and commercialization of new drugs. Small animal imaging is in vivo classification and measurement of biologic process at molecular level which involves the study of specific targeted molecule. Small animal imaging includes micro CT, micro MRI, digital angiography, micro SPECT, micro PET magnetic particle imaging and x-ray imaging.
Small animal imaging market is an emerging due to the advancements in technology and increase in healthcare expenditure. There is an enormous increase in pharmaceutical companies and research institutions elevation in usage of small animal imaging techniques across the globe. Although, high equipment cost and limitation in technology is expected to hinder the market growth of small animal imaging market over the forecast period.
Also, surviving in highly competitive market and inaccessibility of radiopharmaceuticals are the main challenges to overcome for small players. Whereas, innovations in MRI imaging techniques as well in other imaging techniques, usage in many applications and emerging markets are some of the favorable factors for small animal imaging market growth.
Small animal imaging market is also being affected by some factors such as insufficient infrastructure for research amenities and shortage of skilled personnel in developing regions.
Small animal imaging market is expected to grow at a good pace. Enormous increase in number of pharmaceutical companies and research institutions, rise in usage of functional imaging and growing adoption rate for small animal imaging are the factors expected to boost the market growth over the forecast period.
The swift progression in technology, many applications and growing base of research are some of the key factors to drive the growth of small animal imaging globally.Emerging countries will be growing with a faster CAGR related to other parts of the world as expenditure in these region on research is growing.
Depending on geographic region, small animal imaging market is segmented into seven key regions: North America, Latin America, Eastern Europe, Western Europe, Asia Pacific and Middle East & Africa.
North America contributes the maximum share in small animal imaging market. Eastern and Western Europe will show a good growth as the need for drug development through small animal imaging will be increasing. Asia Pacific is growing with a significant CAGR for small animal imaging market due to increase in healthcare expenditure and investment in research.
Amongst the Asian countries, China, India and South Korea will be the more promising because of having a good economy and more expenditure on research.
-market-analysis-by-company.webp "Small Animal Imaging (in Vivo) Market Analysis By Company")
Some of the key participating global players in small animal imaging (In vivo) marketare Berthold Technologies, Spectral Instruments Imaging, Agilent Technologies, Inc., Aspect Imaging, Bioscan, Inc., Bruker Corporation, Gamma Medica-Ideas, Inc., Genovis Ab, Li-Cor Biosciences, Life Technologies Corporation, Mediso Medical Imaging Systems, Miltenyi Biotec Gmbh, Perkinelmer, Inc., Promega Corporation, Scanco Medical Ag, Siemens Ag, Sofie Biosciences, Inc., Targeson, Inc., Uvp. LLC, Fujifilm Holdings Corporation, Thermo Fischer Scientific.
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
-market-cagr-analysis-by-country.webp "Small Animal Imaging (in Vivo) Market Cagr Analysis By Country")
| Country | CAGR |
|---|---|
| China | 10.4% |
| India | 9.6% |
| Germany | 8.9% |
| France | 8.1% |
| UK | 7.3% |
| USA | 6.5% |
| Brazil | 5.8% |
The Small Animal Imaging (In Vivo) Market is expected to register a CAGR of 7.7% during the forecast period, exhibiting varied country level momentum. China leads with the highest CAGR of 10.4%, followed by India at 9.6%. Developed markets such as Germany, France, and the UK continue to expand steadily, while the USA is likely to grow at consistent rates. Brazil posts the lowest CAGR at 5.8%, yet still underscores a broadly positive trajectory for the global Small Animal Imaging (In Vivo) Market. In 2024, Germany held a dominant revenue in the Western Europe market and is expected to grow with a CAGR of 8.9%. The USA Small Animal Imaging (In Vivo) Market is estimated to be valued at USD 460.3 million in 2025 and is anticipated to reach a valuation of USD 867.7 million by 2035. Sales are projected to rise at a CAGR of 6.5% over the forecast period between 2025 and 2035. While Japan and South Korea markets are estimated to be valued at USD 67.9 million and USD 40.8 million respectively in 2025.
| Item | Value |
|---|---|
| Quantitative Units | USD 1.3 Billion |
| Application | Cancer Cell Detection, Monitoring Drug Treatment Response, Bio Distribution Studies, Biomarkers, Longitudinal Studies, and Epigenetics |
| Technology | Micro-Magnetic Resonance Imaging (Micro-MRI), Digital Angiography, Ultrasound, Nuclear Imaging, Micro-Positron Emission Tomography (Micro-PET), Micro-Single Photon Emission CT (Micro-SPECT), Optical Imaging (OI), Bioluminescence Imaging, Cerenkov Luminescence Imaging, Others, Micro-Ultrasound Imaging, and Micro-Computerized Tomography (Micro-CT) |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, Middle East & Africa |
| Country Covered | United States, Canada, Germany, France, United Kingdom, China, Japan, India, Brazil, South Africa |
| Key Companies Profiled | Bruker, PerkinElmer, Inc., Siemens AG, Thermo Fisher Scientific Inc., FUJIFILM Holdings Corporation, Mediso, Miltenyi Biotec, Aspect Imaging Ltd., and Promega Corporation |
The global small animal imaging (in vivo) market is estimated to be valued at USD 1.3 billion in 2025.
The market size for the small animal imaging (in vivo) market is projected to reach USD 2.7 billion by 2035.
The small animal imaging (in vivo) market is expected to grow at a 7.7% CAGR between 2025 and 2035.
The key product types in small animal imaging (in vivo) market are cancer cell detection, monitoring drug treatment response, bio distribution studies, biomarkers, longitudinal studies and epigenetics.
In terms of technology, micro-magnetic resonance imaging (micro-mri) segment to command 22.9% share in the small animal imaging (in vivo) market in 2025.
Explore Similar Insights
Small Animal Imaging (In Vivo) Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
Chat With
MaRIA
